Kinetic analysis of high affinity forms of interleukin (IL)-13 receptors: Suppression of IL-13 binding by IL-2 receptor γ chain

Biophysical Journal

Volumn 77, Issue 1, 1999, Pages 154-172

  Kuznetsov, Vladimir A ^a,b,d   Puri, Raj K ^a,c  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b EMANUEL INSTITUTE OF BIOCHEMICAL PHYSICS   (Russian Federation)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d Civilized Software Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 13; INTERLEUKIN 13 RECEPTOR; INTERLEUKIN 2; RECEPTOR SUBUNIT;

ARTICLE; BINDING KINETICS; CARCINOMA CELL; CONTROLLED STUDY; DISSOCIATION; ENDOCYTOSIS; EXOCYTOSIS; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; LIGAND BINDING; MATHEMATICAL MODEL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; RECEPTOR AFFINITY; STEADY STATE;

EID: 0033020428     PISSN: 00063495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3495(99)76879-7     Document Type: Article

References (45)

1. Bajzer, Z., A. Myers, and S. Vuk-Pavlovic. 1989. Binding, internalization, and intracellular processing of proteins interacting with recycling receptors. J. Biol. Chem. 264:13623-13631.
2. Berg, H. C., and E. M. Pursell. 1977. Physics of chemoreception. Biophys. J. 20:193-219.
3. Borisova, L. R., and V. A. Kuznetsov. 1996. Structural-kinetics models of interaction of interleukin-2 (IL-2) with multi-subunit receptor and its internalization. Chem. Phys. Rep. 15:108-125.
4. Caput, D., P. Laurent, M. Kaghad, J.-M. Lelias, S. Lefort, N. Vita, and P. Ferrare. 1996. Cloning and Characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor alpha chain. J. Biol. Chem. 271:16921-16926.
5. Chang, D. Z., Z. Wu, and T. L. Ciardelli. 1996. A point mutation in Interleukin-2 that alters ligand internalization. J. Biol. Chem. 271: 13349-13355.
6. Chaouchi, N., C. Wallon, C. Goujard, G. Tertain, A. Rudent, D. Caput, P. Ferara, A. Minty, A. Vazquez, and L.-F. Delfraissy. 1996. Interleukin-13 inhibits interleukin-2-induced proliferation and protects chronic lymphocytic leukemia B cells from in vitro apoptosis. Blood. 87:1022-1029.
7. Debinski, W., N. I. Obiri, I. Pastan, and R. K. Puri. 1995. A novel chimeric protein composed of interleukin 13 and Pseudomonas exotoxin is highly cytotoxic to human carcinoma cell expressing receptors for interleukin 4. J. Biol. Chem. 270:16775-16780.
8. Donaldson, D. D., M. J. Whitters, L. J. Fitz, T. Y. Neben, H. Fimnnerty, S. L. Henderson, R. M. O'Harra, D. R. Beair, K. J. Turner, C. R. Wood, and M. Collings. 1998. The murine IL-13 receptor alpha 2: molecular cloning, characterization, and comparison with murine IG-13 receptor alpha 1. J. Immunol. 161:2317-2724.
9. Erickson, J., B. Goldstein, D. Holowka, and B. Baird. 1987. The effect of receptor density on the forward rate constant for binding of ligand to cell surface receptors. Biophys. J. 52:657-662.
10. 1 adenosine receptors. Biochemistry. 35:3007-3015.
11. Gex-Fabry, M., and C. DeLisi. 1984. Receptor-mediated endocytosis: a model and its implication for experimental analysis. Am. J. Physiol. 247:R768-R779.
12. Goldstein, B., and M. Dembo. 1995. Approximating the effect of diffusion on reversible reactions at the cell surface: ligand-receptor kinetics. Biophys. J. 68:1222-1230.
13. Goldstein, B., D. Jones, I. G. Kevrekidis, and A. S. Perelson. 1992. Evidence for p55-p75 heterodimers in the absence of IL-2 from Scatchard plot analysis. Intern. Immunol. 4:23-32.
14. Goldstein, B., R. G. Posner, D. C. Torney, J. Erickson, D. Holowka, and B. Baird. 1989. Competition between solution and cell surface receptors for ligand: the dissociation of hapten bound presence of surface antibody in the presence of solution antibody. Biophys. J. 58:955-966.
15. Graber, P., D. Gretener, S. Herren, J. P. Aubry, G. Elson, J. Poudrier, S. Lecoanet-Henchoz, S. Alouani, C. Lisberger, J. Y. Bonnefoy, M. H. Kosco-Vilbois, and J. F. Gauchat. 1998. The distribution of IL-13 receptor alpha 1 expression on B cells, T cells and monocytes and its regulation by IL-113 and IL-4. Eur. J. Immunol. 28:4226-4298.
16. Havlin, S. 1989. Molecular diffusion and reactions. In The Fractal Approach to Heterogeneous Chemistry: Surfaces, Colloids, Polymers. D. Avnir, editor. Wiley and Sons Ltd., New York, NY. 251-269.
17. Keough, K. M. W., P. Hyam, D. A. Pink, and B. Quinn. 1991. Cell surfaces and fractal dimensions. J. Micro. 163:95-99.
18. Knott, G. 1996. MLAB: A mathematical modeling laboratory. Civilized Software, Bethesda, MD.
19. Kuznetsov, V. A. 1990. Computer analysis of receptor-mediated endocytosis and exocytosis mechanisms: two pathways for the progressing of Ti/CD3 receptor complexes of T lymphocytes. Biomed. Sci. 1:631-638.
20. Kuznetsov, V. A. 1996. Basic models of tumor-immune system interactions: identification, analysis and predictions. In A Survey of Models for Tumor-Immune System Dynamics. J. A. Adam and N. Bellomo, editors. Birkhauser, Boston, MA. 237-290.
21. Kuznetsov, V. A., and L. P. Borisova. 1995a. Kinetics model of the interleukin-4 (IL-4) binding to high affinity IL-4 receptor and their internalization. In Differential Equations and Applications to Biology and to Industry. M. Martelli, K. Cooke, E. Cumberbatch, B. Tang, H. Thieme, editors. Word Science Publishing Co., Singapore-N.Y.-London-Hong Kong-Bangalore. 271-280.
22. Kuznetsov, V. A., and L. R. Borisova. 1995b. Kinetic analysis of the internalization and shedding of interleukin-2 from surface of cells expressing receptors of different affinity. Membr. and Cell Biol. 8:591-604.
23. Kuznetsov, V. A., V. P. Zhivoglyadov, and L. A. Stepanova. 1993. Kinetic approach and estimation of parameters of cellular interaction between immunity system and a tumor. Arch. Immunol. Ther. Exp. 41:21-31.
24. Matsuoka, M., T. Takeshita, N. Ishii, M. Nakamura, T. Ohkubo, and K. Sugamura. 1993. Kinetic study of interleukin-2 binding on the reconstituted interleukin-2 receptor complex including the human γ chain. Eur. J. Immunol. 23:2472-2476.
25. McKenzie, A. N. J., J. A. Culpepper, R. de Waal Malefyt, F. Briere, J. Punnonen, G. Aversa, A. Sato, W. Dang, B. G. Cocks, S. Menon, J. E. de Vries, J. Blanchereau, and G. Zurawski. 1993. Interleukin-13, a T cell-derived cytokine that regulate human monocyte and B cell function. Proc. Natl. Acad. Sci. USA. 90:3735-3739.
26. Minty, A., P. Chalon, J.-M. Derocq, X. Dumount, J.-C. Gullemot, M. Kaghad, C. Labit, P. Leplatois, P. Laiauzun, B. Miloux, C. Minty, P. Casellas, G. Loison, J. Lupker, D. Shire, P. Ferrara, and D. Caput. 1993. Interleukin-13 is a new lymphokine regulating inflammatory and immune responses. Nature. 362:248-250.
27. Murata, T., N. Obiri, W. Debinski, and R. K. Puri. 1998. Structure of IL-13 receptor: analysis of subunit composition in cancer and immune cells. Biochem. Biophys. Res. Comm. 238:90-94.
28. Nonnenmacher, T. F., G. Baumann, A. Barth, and G. A. Losa. 1994. Digital image analysis of self-similar cell profiles. Int. J. Biomed. Computing. 37:131-138.
29. Obiri, N. I., W. Debinski, W. J. Leonard, and R. K. Puri. 1995. Receptor for interleukin 13. Interaction with interleukin 4 by a mechanism that does not involve the common γ chain shred by receptors for interleukins 2, 4, 7, 9 and 15. J. Biol. Chem. 270:8797-8804.
30. Obiri, N. I., G. Hillman, G. P. Haas, S. Sudha, and R. K. Puri. 1993. Expression of high affinity Interleukin-4 receptors on human renal carcinoma cells and inhibition of tumor growth in vitro by Interleukin-4. J. Clin. Invest. 91:88-93.
31. Obiri, N. I., S. R. Husain, W. Debinski, and R. K. Puri. 1996a. Interleukin 13 inhibits growth of human renal cell carcinoma cells independently of the p140 interleukin 4 receptor chain. Clin. Cancer Res. 2:1743-1749.
32. c chain of the IL-2 receptor. J. Biol. Chem. 272:20251-20258.
33. Obiri, N. I., P. Leland, T. Murata, W. Debinski, and R. K. Puri. 1997. The IL-13 receptor structure differs on various cell types and may share more than one component with IL-4 receptor. J. Immunol. 158:756-764.
34. Obiri, N. I., and R. K. Puri. 1994. Characterization of IL-4 receptor expressed on human renal carcinoma cells. Oncol. Res. 6:419-427.
35. Park, L. S., D. Friend, H. M. Sassenfield, and D. L. Urdal. 1987. Characterization of the human B cell stimulatory factor 1 receptor. J. Exp. Med. 166:476-488.
36. Posner, R. G., B. Lee, D. H. Conrad, D. Holowka, B. Baird, and B. Goldstein. 1992. Aggregation of IgE-receptor complex on rat basophilic leukemia cells does not change the intrinsic affinity but can alter the kinetics of the ligand-IgE interaction. Biochemistry. 31:5350-5356.
37. Puri, R. K., N. I. Obiri, S. R. Husain, R. J. Kreitman, G. P. Haas, I. Pastan, and W. Debinski. 1996a. Targering of interleukin 13 receptors on human renal cell carcinoma cells by a recombinant chimeric protein composed of interleukin-13 and trucated form of Pseudomonas exotoxin A (PE38QQ8). Blood. 87:4333-4339.
38. c chain in RCC cells does not improve sensitivity. Cell. Immunol. 171:80-86.
39. Rovati, G. E., R. Shrager, S. Nicosia, and P. J. Munson. 1996. KINET II: a nonlinear least-squares program for analysis of kinetic binding data. Mol. Pharmacol. 50:86-95.
40. Sadana, A., and A. M. Beelaram. 1996a. Antigen-antibody diffusion-limited binding kinetics for biosensors. A fractal analysis. Appl. Biochem. Biotech. 59:259-282.
41. Sadana, A., and A. M. Beelaram. 1996b. Antigen-antibody binding kinetics for biosensors: changes in fractal dimension (surface roughness) and in the binding rate coefficient. Appl. Biochem. Biotech. 60:123-1138.
42. de Waal Malefyt, R., C. G. Figdor, R. Hui Jbens, S. Mohan-Peterson, B. Bennett, J. Culpepper, W. Dang, G. Zurawski, and J. E. de Vries. 1993. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparision with IL-4 and modulation by IFN-γ or IL-10. J. Immunol. 150:6370-6376.
43. Wofsy, C., B. Goldstein, K. Lung, and H. S. Willey. 1992. Implications of epidermal growth factor (EGF) induced EGF receptor aggregation. Biophys. J. 63:98-110.
44. Zhang, J. G., D. J. Hilton, T. A. Willson, C. McFarlane, B. A. Roberts, R. L. Moritz, R. J. Simpson, W. S. Alexamder, D. Metcalf, and N. A. Nicola. 1997. Identification, purification, and characterization of a soluble Interleukin (IL)-13-binding protein. J. Biol. Chem. 282:9474-9480.
45. Zurawski, G., and J. E. de Vries. 1994. Interleukin-13 and Interleukin-4-like cytokine that acts on monocytes and B cells but not on T cells. Immunol. Today. 15:19-26.